BRPI0819224A2 - Hidrato cristalino de beta-mimético e o uso como medicamento do mesmo - Google Patents

Hidrato cristalino de beta-mimético e o uso como medicamento do mesmo

Info

Publication number
BRPI0819224A2
BRPI0819224A2 BRPI0819224A BRPI0819224A2 BR PI0819224 A2 BRPI0819224 A2 BR PI0819224A2 BR PI0819224 A BRPI0819224 A BR PI0819224A BR PI0819224 A2 BRPI0819224 A2 BR PI0819224A2
Authority
BR
Brazil
Prior art keywords
mimetic
hydrate
medicine
crystalline beta
beta
Prior art date
Application number
Other languages
English (en)
Inventor
Michael Aven
Peter Sieger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40243788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0819224(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BRPI0819224A2 publication Critical patent/BRPI0819224A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0819224 2007-11-05 2008-10-21 Hidrato cristalino de beta-mimético e o uso como medicamento do mesmo BRPI0819224A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07119948 2007-11-05
PCT/EP2008/064201 WO2009059893A1 (en) 2007-11-05 2008-10-21 Crystalline hydrate of betamimetika and use as medicament thereof

Publications (1)

Publication Number Publication Date
BRPI0819224A2 true BRPI0819224A2 (pt) 2015-05-05

Family

ID=40243788

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819224 BRPI0819224A2 (pt) 2007-11-05 2008-10-21 Hidrato cristalino de beta-mimético e o uso como medicamento do mesmo

Country Status (14)

Country Link
US (1) US20100331288A1 (pt)
EP (1) EP2217582A1 (pt)
JP (1) JP2011502967A (pt)
KR (1) KR20100088148A (pt)
CN (1) CN101848900A (pt)
AR (1) AR069186A1 (pt)
AU (1) AU2008324285A1 (pt)
BR (1) BRPI0819224A2 (pt)
CA (1) CA2703511A1 (pt)
CL (1) CL2008003292A1 (pt)
MX (1) MX2010004521A (pt)
TW (1) TW200934766A (pt)
WO (1) WO2009059893A1 (pt)
ZA (1) ZA201001817B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
BRPI0614410A2 (pt) 2005-08-15 2011-03-29 Boehringer Ingelheim Int processo para preparação de betamiméticos
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
WO2009059893A1 (en) 2009-05-14
ZA201001817B (en) 2010-12-29
KR20100088148A (ko) 2010-08-06
TW200934766A (en) 2009-08-16
JP2011502967A (ja) 2011-01-27
MX2010004521A (es) 2010-08-04
AR069186A1 (es) 2010-01-06
CL2008003292A1 (es) 2010-01-11
EP2217582A1 (en) 2010-08-18
CA2703511A1 (en) 2009-05-14
US20100331288A1 (en) 2010-12-30
CN101848900A (zh) 2010-09-29
AU2008324285A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
NO2025055I1 (no) Clascoterone and crystalline forms thereof
BRPI0821668A2 (pt) Uso
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
GB0701426D0 (en) Compounds and their use
BRPI0814344A2 (pt) Injetor descartável com êmbolo manobrável manualmente
EP2131749A4 (en) Surgical stapling apparatus
EP2117490A4 (en) DISPOSABLE TRANSPORTER
BR112012002349A2 (pt) composto,e, uso do mesmo
GB0700580D0 (en) Use
BRPI1007494A2 (pt) composto e uso do mesmo
DE502008001632D1 (de) Karosserieaufbau
BRPI0812991A2 (pt) Utilização de combustível melhorado
GB0714670D0 (en) Use
GB0712503D0 (en) Use
EP2197448A4 (en) dosing schedule
BRPI1011036A2 (pt) uso
BRPI0920502A2 (pt) compostos cicloundecadepsipeptídeos e seu uso como medicamento
BRPI1013597A2 (pt) seringa para uso único
DE502007004713D1 (de) Karosserie-Anbauteil
BRPI0819224A2 (pt) Hidrato cristalino de beta-mimético e o uso como medicamento do mesmo
BRPI1009090A2 (pt) composto, pró-droga, medicamento, métodos, e, uso do composto
BRPI0809936A2 (pt) Composto sulfonado de açúcar e uso do mesmo como medicamento
GB0723476D0 (en) Surgical stop element
DE602007002470D1 (de) Wabenstrukturkörper
EP2162546A4 (en) PNEUMOKOKEN SEROTYPE 6D

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.